Abbott Laboratories
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Abbott Laboratories's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 8% to $40,109,000,000. Profit margin reached 14%. Total operating expenses were $15,656,000,000.

Profit Margin

Abbott Laboratories (NYSE:ABT): Profit margin
2014 20.24B 2.28B 11.28%
2015 20.40B 4.42B 21.68%
2016 20.85B 1.4B 6.71%
2017 27.39B 477M 1.74%
2018 30.57B 2.36B 7.74%
2019 31.90B 3.68B 11.56%
2020 34.60B 4.49B 12.99%
2021 43.07B 7.07B 16.42%
2022 43.65B 6.93B 15.88%
2023 40.10B 5.72B 14.27%

ABT Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
40.10B43.65B43.07B34.60B31.90B30.57B27.39B20.85B20.40B20.24B
Cost of revenue
17.97B19.14B18.53B15.00B13.23B12.70B12.33B9.02B8.74B9.21B
Gross profit
22.13B24.51B24.53B19.60B18.67B17.87B15.05B11.82B11.65B11.02B
Operating exp.
Research and development
2.74B2.88B2.74B2.42B2.44B2.3B2.23B1.42B1.40B1.34B
Selling and marketing
0000000000
Total operating expenses
15.65B16.14B16.11B14.24B14.14B14.22B13.32B8.64B8.79B8.43B
Operating income
6.47B8.36B8.42B5.35B4.53B3.65B1.72B3.18B2.86B2.59B
Other income (expenses), net
186M-56M-214M-389M-455M-56M667M-1.44B316M-81M
Income before tax
6.66B8.30B8.21B4.96B4.07B2.87B2.23B1.41B3.18B2.51B
Income tax expense
941M1.37B1.14B497M390M539M1.87B350M577M797M
Net income
5.72B6.93B7.07B4.49B3.68B2.36B477M1.4B4.42B2.28B
Earnings per share
Basic EPS
3.33.943.972.522.071.350.270.9531.51
Diluted EPS
3.273.913.942.52.061.340.270.942.941.5
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source